5
Veerhealth Care Ltd
VEERHEALTHCARELTD NSE
Veerhealth Care Ltd
HealthcareNSE: VEERHEALTHCARELTD BSE: 511523 Pharmaceuticals & Biotechnology
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹82.86 Cr
Volatility
High Risk
P/E Ratio
153.6
EBITDA
₹2.15 Cr
Return on Equity
1.76%
Debt to Equity
0.2
Book Value
₹11.46
EPS
₹0.2
52W High
₹41.5
52W Low
₹16.7
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Veerhealth Care Ltd insights
39 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is expected to give good quarter
- Company's working capital requirements have reduced from 158 days to 51.4 days
Weaknesses
4- Stock is trading at 3.62 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 31.9%
- Company has a low return on equity of 2.22% over last 3 years.
Growth Rate
Revenue Growth
81.45% ↘
Net Income Growth
160.00% ↗
Cash Flow Change
-113.45% ↘
ROE
-5.38% ↘
ROCE
-49.90% ↘
EBITDA Margin (Avg.)
-31.20% ↗
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.73 | 3.58 | 3.83 | 2.87 | 3.37 | 2.06 | 5.15 | 3.84 | 5.62 | 4.49 | 3.98 | 7.26 | 16.76 |
| Expenses | 3.36 | 3.15 | 3.62 | 2.7 | 3.2 | 2.08 | 4.67 | 3.69 | 5.78 | 4.52 | 3.45 | 6.02 | 16.03 |
| Operating Profit | 0.37 | 0.43 | 0.21 | 0.17 | 0.17 | -0.02 | 0.48 | 0.15 | -0.16 | -0.03 | 0.53 | 1.24 | 0.73 |
| OPM % | 9.92% | 12.01% | 5.48% | 5.92% | 5.04% | -0.97% | 9.32% | 3.91% | -2.85% | -0.67% | 13.32% | 17.08% | 4.36% |
| Other Income | 0.28 | 0.15 | 0.42 | 0.24 | 0.17 | 0.36 | 0.25 | 0.18 | 0.43 | 0.65 | 0.23 | -0.29 | -0.09 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | 0.01 | 0.14 | 0.1 | 0.1 | 0.1 | 0.11 |
| Depreciation | 0.16 | 0.18 | 0.18 | 0.18 | 0.18 | 0.19 | 0.2 | 0.25 | 0.26 | 0.28 | 0.31 | 0.35 | 0.35 |
| PBT | 0.49 | 0.4 | 0.45 | 0.23 | 0.16 | 0.15 | 0.42 | 0.07 | -0.13 | 0.24 | 0.35 | 0.5 | 0.18 |
| Tax % | -112.24% | 15% | 13.33% | 17.39% | 443.75% | 20% | 28.57% | 0% | -23.08% | 0% | 25.71% | 18% | 294.44% |
| Net Profit | 1.04 | 0.34 | 0.39 | 0.19 | -0.55 | 0.12 | 0.3 | 0.07 | -0.1 | 0.24 | 0.25 | 0.4 | -0.35 |
| EPS in Rs | 0.52 | 0.17 | 0.2 | 0.1 | -0.28 | 0.06 | 0.15 | 0.04 | -0.05 | 0.12 | 0.13 | 0.2 | -0.18 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.33 | 2.14 | 1.89 | 5.17 | 5.98 | 11.72 | 10.62 | 9.64 | 13.28 | 13.22 | 16.67 | 32.48 |
| Expenses | 1.48 | 2.16 | 2.25 | 5.29 | 5.54 | 11.04 | 10.56 | 10.46 | 12.78 | 12.61 | 16.21 | 30.02 |
| Operating Profit | -0.15 | -0.02 | -0.36 | -0.12 | 0.44 | 0.68 | 0.06 | -0.82 | 0.5 | 0.61 | 0.46 | 2.46 |
| OPM % | -11.28% | -0.93% | -19.05% | -2.32% | 7.36% | 5.8% | 0.56% | -8.51% | 3.77% | 4.61% | 2.76% | 7.57% |
| Other Income | 0.48 | 0.38 | 0.72 | 0.72 | 0.29 | 0.48 | 1.2 | 1.67 | 1.24 | 1.39 | 1.22 | 0.49 |
| Interest | 0.06 | 0.13 | 0.1 | 0.07 | 0.03 | 0.19 | 0.22 | 0.09 | 0 | 0.01 | 0.26 | 0.4 |
| Depreciation | 0.11 | 0.21 | 0.23 | 0.27 | 0.32 | 0.32 | 0.47 | 0.52 | 0.62 | 0.71 | 0.91 | 1.29 |
| PBT | 0.16 | 0.02 | 0.03 | 0.26 | 0.38 | 0.65 | 0.57 | 0.24 | 1.12 | 1.28 | 0.51 | 1.26 |
| Tax % | 62.5% | 100% | 33.33% | 42.31% | 57.89% | 50.77% | 35.09% | 129.17% | -41.07% | 68.75% | 23.53% | 56.35% |
| Net Profit | 0.06 | 0.01 | 0.02 | 0.14 | 0.16 | 0.32 | 0.38 | -0.07 | 1.58 | 0.41 | 0.39 | 0.54 |
| EPS in Rs | 0.04 | 0.01 | 0.01 | 0.1 | 0.12 | 0.23 | 0.27 | -0.05 | 0.79 | 0.21 | 0.2 | 0.27 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 10 | 20 | 20 | 20 |
| Reserves | 5.86 | 5.88 | 5.92 | 6.17 | 6.35 | 6.82 | 7.11 | 7.02 | 11.43 | 1.84 | 2.22 | 2.92 |
| Borrowings | 1.01 | 1.08 | -0.17 | 1.21 | 0.94 | 2.48 | 1.73 | 0 | 0 | 0 | 4.91 | 4.58 |
| Other Liabilities | 0.24 | 0.23 | 0.37 | 0.42 | 1.94 | 1.76 | 2.96 | 6.2 | 3.82 | 6.28 | 6.65 | 16.67 |
| Total Liabilities | 14.04 | 14.12 | 13.05 | 14.73 | 16.16 | 17.99 | 18.73 | 20.15 | 25.25 | 28.12 | 33.78 | 44.17 |
| Fixed Assets | 2.07 | 2.71 | 2.52 | 5.54 | 5.46 | 9.45 | 9.48 | 10.54 | 12.01 | 11.97 | 19.87 | 23.43 |
| CWIP | 0 | 0 | 0 | 0.24 | 2.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 11.97 | 11.41 | 10.53 | 8.95 | 8.51 | 8.54 | 9.25 | 9.61 | 13.24 | 16.15 | 13.91 | 20.74 |
| Total Assets | 14.04 | 14.12 | 13.05 | 14.73 | 16.16 | 17.99 | 18.73 | 20.15 | 25.25 | 28.12 | 33.78 | 44.17 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -3.73 | 0 | 1.69 | 1.76 | 1.98 | -0.36 | 1 | 1.81 | -0.7 | 2.9 | -0.39 | 4.19 |
| Investing | 3.85 | -0.01 | -0.44 | -3.02 | -1.9 | -1.67 | -0.09 | -1.09 | -1.79 | -0.28 | -8.2 | -4.43 |
| Financing | 0 | 0 | -1.33 | 1.31 | 0.02 | 1.85 | -0.83 | -0.42 | 5.69 | -5.99 | 9.52 | -0.46 |
| Net Cash Flow | 0.12 | -0.01 | -0.08 | 0.06 | 0.1 | -0.17 | 0.09 | 0.3 | 3.21 | -3.37 | 0.92 | -0.7 |
| Free Cash Flow | -1.02 | -0.76 | 1.66 | -1.78 | -0.21 | -2.48 | 0.5 | 0.23 | -2.79 | 2.22 | -9.2 | -0.67 |
| CFO/OP | 2,533 | 50 | -253 | -1,550 | 480 | -44 | 2,050 | -226 | -100 | 523 | -65 | 179 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 255 | 152 | 118 | 64.95 | 45.17 | 29.27 | 52.93 | 58.31 | 50.57 | 108 | 70.28 | 109 |
| Inventory Days | 230 | 444 | 477 | 93.49 | 77.82 | 54.35 | 76.21 | 103 | 103 | 55.97 | 78.12 | 67.26 |
| Days Payable | 55 | 31.74 | 68.63 | 18.9 | 145 | 37.12 | 42.24 | 112 | 21.75 | 86.35 | 83.89 | 183 |
| Cash Conversion Cycle | 430 | 564 | 526 | 140 | -22.46 | 46.51 | 86.9 | 48.61 | 132 | 77.85 | 64.52 | -6.47 |
| Working Capital Days | 2,121 | 1,049 | 1,597 | 394 | 8.55 | 145 | 177 | 128 | 158 | 289 | 135 | 51.36 |
| ROCE % | -0.15% | 1.08% | 0.98% | 2.45% | 2.87% | 5.52% | 4.94% | 2.22% | 6.33% | 5.96% | 3.14% | 7.21% |
Documents
1
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
1d - Received Rs 15.73 lakh export order for Gripe Water from Sudan, to execute within 45 days. 1d - Received Rs 15.73 lakh export order for Gripe Water from Sudan, to execute within 45 days.
3
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
1 May - Postal ballot approved issuance of up to 1,00,00,000 fully convertible warrants on preferential basis. 1 May - Postal ballot approved issuance of up to 1,00,00,000 fully convertible warrants on preferential basis.
4
Announcement under Regulation 30 (LODR)-Press Release / Media Release
30 Apr - Veerhealth Care received repeat order worth ₹1.43 crore from a leading US e-commerce platform. 30 Apr - Veerhealth Care received repeat order worth ₹1.43 crore from a leading US e-commerce platform.
5
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
29 Apr - Received repeat international body care products order worth $151,200 (₹143 lakh), executable in 45 days. 29 Apr - Received repeat international body care products order worth $151,200 (₹143 lakh), executable in 45 days.
Frequently Asked Questions about Veerhealth Care Ltd
What does Veerhealth Care Ltd do?
Incorporated in 1992, Veer Healthcare Ltd is in the business of trading, manufacturing and marketing research based ayurvedic medicines[1]
Where is Veerhealth Care Ltd (511523) listed?
Veerhealth Care Ltd is listed on the Indian stock exchanges. It is listed on NSE: VEERHEALTHCARELTD and BSE: 511523. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Veerhealth Care Ltd belong to?
Veerhealth Care Ltd operates in the Healthcare sector within the Pharmaceuticals & Biotechnology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Veerhealth Care Ltd?
Veerhealth Care Ltd has a market capitalisation of approximately ₹82.86 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Veerhealth Care Ltd?
The Price-to-Earnings (PE) ratio of Veerhealth Care Ltd is 153.60. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Veerhealth Care Ltd?
Over the past 52 weeks, Veerhealth Care Ltd has traded between a low of ₹16.7 and a high of ₹41.5. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Veerhealth Care Ltd?
Veerhealth Care Ltd has a Return on Equity (ROE) of 1.76%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Veerhealth Care Ltd on Tapetide?
On Tapetide, you can view Veerhealth Care Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1992, Veer Healthcare Ltd is in the business of trading, manufacturing and marketing research based ayurvedic medicines[1]
Website veerhealthcare.net
Face Value ₹ 10